Literature DB >> 6342881

Analysis with monoclonal antibodies of human lymphoid cells forming rosettes with rabbit red blood cells.

R Munker, K Stünkel, E Thiel, S Thierfelder.   

Abstract

Rabbit red blood cells have previously been shown to rosette with a subpopulation of thymocytes and with mitogen activated peripheral lymphocytes but not with unstimulated lymphocytes. Using monoclonal antibodies and double marker assays we studied the phenotype of these cells. In thymus, over 90% of rosetting cells express antigens of immature thymocytes (HTA1, OKT6). A proportion of the rosetting cells shows in addition antigens of mature thymocytes (OKT3, UCHT1). These cells probably correspond to a stage of intrathymic maturation between common and mature thymocytes. Virtually all rosetting cells are T cells and express an antigen related to T cell activation (TAC) when lymphocytes are activated by mitogens like PHA or Con A. Few rosetting cells are Ia positive. Two other antigens (OKT9, OKT10) known to be associated with proliferating and immature cells, are found in variable proportions on rosetting cells. After stimulation with allogeneic lymphocytes, fewer rosettes are detected than after stimulation by mitogens. Cells activated by a soluble antigen (PPD) and forming rosettes with rabbit red blood cells have a helper phenotype (Leu3a positive). Screening of leukaemia cell samples revealed that only cells from patients with T-ALL form rosettes with rabbit red blood cells. Rosette formation is almost totally inhibited by a polyclonal anti-thymocyte serum and two monoclonal antibodies (OKT11A,Lyt3) which have been shown to block rosettes with sheep erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342881      PMCID: PMC1536787     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes.

Authors:  S Gupta; R A Good; F P Siegal
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

2.  Rosette formation with goat erythrocytes. A marker for human T lymphocytes.

Authors:  F Pandolfi; J T Kurnick; K Nilsson; K Forsbeck; H Wigzell
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

3.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

4.  The significance of the "active" E-rosette-forming cell.

Authors:  R B Traycoff; J Wortsman; W L Myers; W Rogers
Journal:  Clin Immunol Immunopathol       Date:  1979-08

5.  Analysis of cell populations with a fluorescence-activated cell sorter.

Authors:  M R Loken; L A Herzenber
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

6.  E receptors on blasts from untreated acute lymphocytic leukemia (ALL): comparison of temperature dependence of E rosettes formed by normal and leukemic lymphoid cells.

Authors:  L Borella; L Sen
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

7.  A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.

Authors:  A J McMichael; J R Pilch; G Galfré; D Y Mason; J W Fabre; C Milstein
Journal:  Eur J Immunol       Date:  1979-03       Impact factor: 5.532

8.  Human lymphocytes subpopulations: rabbit red blood cell rosettes.

Authors:  D T Yu; R P Gale
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

9.  Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.

Authors:  U Schneider; H U Schwenk; G Bornkamm
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

10.  Studies on rosette formation of human lymphocytes with pig red blood cells.

Authors:  J S Smolen; U Youngchaiyud; W J Pichler; M Binder; C Steffen; W Knapp
Journal:  Int Arch Allergy Appl Immunol       Date:  1978
View more
  3 in total

1.  Monitoring of interleukin-2 receptor (IL-2R) expression in vivo and studies on an IL-2R-directed immunosuppressive therapy of active and adoptive adjuvant-induced arthritis in rats.

Authors:  K G Stünkel; P Theisen; A Mouzaki; T Diamantstein; H D Schlumberger
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

2.  Monoclonal antibodies against differentiation antigens of lymphopoiesis.

Authors:  E Thiel
Journal:  Blut       Date:  1983-11

3.  Ciprofloxacin enhances T cell function by modulating interleukin activities.

Authors:  K G Stünkel; G Hewlett; H J Zeiler
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.